Trial · NCT02617446
Registered outcomes26
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 26
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in E/Ea Ratio | 24 hours | Change from baseline at 24 hours in the unitless ratio of E (cm/sec) to Ea (or e') (cm/sec) as measured by echocardiogram. The endpoint is the Tissue Doppler echocardiography showing measurement of mitral E/Ea ratio for assessment of diastolic dysfunction. Initially mitral E wave is measured. After that, color Tissue Doppler (tissue velocity imaging or TVI) mode is switched on to assess tissue Doppler. The cursor is placed over the medial mitral annulus and tissue Doppler tracing obtained. This allows Ea velocity to be measured. Higher values are suggestive of a worse outcome; less than 8 is normal. |
| Secondary | Change in LVEF | 24 hours | Change from baseline at 24 hours in LV ejection fraction (LVEF) by tissue Doppler |
| Secondary | Change in SVI | 24 hours | Change from baseline at 24 hours in stroke volume index (SVI) by tissue Doppler |
| Secondary | Change in E/A Ratio | 24 hours | Change from baseline at 24 hours in E/A ratio by tissue Doppler |
| Secondary | Change in LV End Systolic Volume | 24 hours | Change from baseline in left ventricular end systolic volume (LVESV) by tissue Doppler |
| Secondary | Change in LV End Diastolic Volume | 24 hours | Change from baseline in left ventricular end diastolic volume (LVEDV) by tissue Doppler |
| Secondary | Change in Dyspnea | 24 hours | Measured using a visual analog scale (0 to 100). Higher scores indicate less dyspnea. |
| Other | Change in cTnT | 24 hours | Safety endpoint: Changes in troponin (cTnT) |
| Other | Change in eGFR | 24 Hours | Safety endpoint: Change from baseline in estimated glomerular filtration rate (eGFR) |
| Other | Participants With Clinically or Hemodynamically Significant Episodes of Arrhythmias | 24 hours | Safety endpoint: Number of participants with incidence of clinically or hemodynamically significant episodes of supraventricular or ventricular arrhythmias detected by continuous ECG dynamic monitoring |
| Other | PR Interval | 24 Hours | Safety Endpoint: The PR interval, measured in milliseconds, extends from the beginning of the P wave (the onset of atrial depolarization) until the beginning of the QRS complex (the onset of ventricular depolarization). |
| Other | QRS Duration | 24 hours | Safety endpoint: The quasi-random signal (QRS) duration represents the time for ventricular depolarization, normally 0.06 to 0.10 seconds. |
| Other | QTc Interval | 24 Hours | Safety Endpoint: The corrected QT interval (QTc) on an ECG represents the duration in milliseconds of the ventricular action potential, which physiologically correlates with the duration of the ventricular depolarization and repolarization. |
| Other | All-Cause Mortality at Day 30 | 30 days | Safety endpoint: Mortality at Day 30 |
| Other | RBC - Shift | Day 3 | Safety endpoint: Baseline normal/abnormal to Day 3 normal/abnormal in red blood cells (RBC) |
| Other | Hematocrit - Shift | Day 3 | Safety endpoint: Baseline normal/abnormal to Day 3 normal/abnormal in hematocrit |
| Other | Hemoglobin - Shift | Day 3 | Safety endpoint: Baseline normal/abnormal to Day 3 normal/abnormal in hemoglobin |
| Other | White Blood Cells (WBC) - Shift | Day 3 | Safety endpoint: Baseline normal/abnormal to Day 3 normal/abnormal in WBC |
| Other | Platelets - Shift | Day 3 | Safety endpoint: Baseline normal/abnormal to Day 3 normal/abnormal in platelets |
| Other | Potassium - Shift | Day 3 | Safety endpoint: Baseline normal/abnormal to Day 3 normal/abnormal in potassium |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02617446/registered